The impact of symptoms and comorbidity on health utility scores and health-related quality of life in small cell lung cancer using real world data

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases · 1987 · 49.9K citations

Public Health, Biostatistics, Clinical Classification Systems +15

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

Michael Herdman, Claire Gudex, Andrew Lloyd et al. · Quality of Life Research · 2011 · 10K citations · Full text

Pharmacy, Psychology, Health Assessment +16

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Leora Horn, Aaron S. Mansfield, Aleksandra Szczęsna et al. · New England Journal of Medicine · 2018 · 3.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study

Mathieu F. Janssen, A. Simon Pickard, Dominik Golicki et al. · Quality of Life Research · 2012 · 1.6K citations · Full text

Pharmacy, Health Sciences, Health Assessment +16

Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

Andrew T. Turrisi, KyungMann Kim, Ronald H. Blum et al. · New England Journal of Medicine · 1999 · 1.5K citations · Full text

Medicine, Oncology, Radiation Oncology +11